Genetic variation and urine cadmium levels: ABCC1 effects in the Strong Heart Family Study.


Journal

Environmental pollution (Barking, Essex : 1987)
ISSN: 1873-6424
Titre abrégé: Environ Pollut
Pays: England
ID NLM: 8804476

Informations de publication

Date de publication:
01 May 2021
Historique:
received: 25 09 2020
revised: 03 02 2021
accepted: 07 02 2021
pubmed: 1 3 2021
medline: 7 4 2021
entrez: 28 2 2021
Statut: ppublish

Résumé

Genetic effects are suspected to influence cadmium internal dose. Our objective was to assess genetic determinants of urine cadmium in American Indian adults participating in the Strong Heart Family Study (SHFS). Urine cadmium levels and genotyped short tandem repeat (STR) markers were available on 1936 SHFS participants. We investigated heritability, including gene-by-sex and smoking interactions, and STR-based quantitative trait locus (QTL) linkage, using a variance-component decomposition approach, which incorporates the genetic information contained in the pedigrees. We also used available single nucleotide polymorphisms (SNPs) from Illumina's Metabochip and custom panel to assess whether promising QTLs associated regions could be attributed to SNPs annotated to specific genes. Median urine cadmium levels were 0.44 μg/g creatinine. The heritability of urine cadmium concentrations was 28%, with no evidence of gene-by-sex or -smoking interaction. We found strong statistical evidence for a genetic locus at chromosome 16 determining urine cadmium concentrations (Logarithm of odds score [LOD] = 3.8). Among the top 20 associated SNPs in this locus, 17 were annotated to ABCC1 (p-values from 0.0002 to 0.02), and attenuated the maximum linkage peak by a ∼40%. Suggestive QTL signals (LOD>1.9) in chromosomes 2, 6, 11, 14, and 19, showed associated SNPs in the genes NDUFA10, PDE10A, PLEKHA7, BAZ1A and CHAF1A, respectively. Our findings support that urinary cadmium levels are heritable and influenced by a QTL on chromosome 16, which was explained by genetic variation in ABCC1. Studies with extended sets of genome-wide markers are needed to confirm these findings and to identify additional metabolism and toxicity pathways for cadmium.

Identifiants

pubmed: 33640655
pii: S0269-7491(21)00297-9
doi: 10.1016/j.envpol.2021.116717
pmc: PMC8026674
mid: NIHMS1672822
pii:
doi:

Substances chimiques

BAZ1A protein, human 0
Chromosomal Proteins, Non-Histone 0
Multidrug Resistance-Associated Proteins 0
Cadmium 00BH33GNGH
PDE10A protein, human EC 3.1.4.-
Phosphoric Diester Hydrolases EC 3.1.4.-
multidrug resistance-associated protein 1 Y49M64GZ4Q

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

116717

Subventions

Organisme : NHLBI NIH HHS
ID : U01 HL041654
Pays : United States
Organisme : NIEHS NIH HHS
ID : R01 ES025216
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL090863
Pays : United States
Organisme : NIEHS NIH HHS
ID : P42 ES010349
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL109315
Pays : United States
Organisme : NHLBI NIH HHS
ID : 75N92019D00030
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL109319
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL109284
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL065521
Pays : United States
Organisme : NHLBI NIH HHS
ID : 75N92019D00027
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL109301
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL109282
Pays : United States
Organisme : NIEHS NIH HHS
ID : P30 ES009089
Pays : United States
Organisme : NIEHS NIH HHS
ID : P30 ES010126
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL041642
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL041652
Pays : United States
Organisme : NHLBI NIH HHS
ID : 75N92019D00029
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL065520
Pays : United States
Organisme : NIEHS NIH HHS
ID : R01 ES021367
Pays : United States

Informations de copyright

Copyright © 2021 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Références

Environ Health Perspect. 2012 Feb;120(2):204-9
pubmed: 22062584
Neurotoxicology. 1998 Aug-Oct;19(4-5):529-35
pubmed: 9745907
Hum Hered. 2002;54(2):99-110
pubmed: 12566741
Prog Food Nutr Sci. 1984;8(1-2):109-63
pubmed: 6385135
Environ Pollut. 2020 Aug;263(Pt A):114484
pubmed: 32268232
PLoS One. 2019 Oct 17;14(10):e0223574
pubmed: 31622379
Aquat Toxicol. 2017 May;186:123-133
pubmed: 28282619
Hum Mol Genet. 2016 Jun 1;25(11):2342-2348
pubmed: 27005419
Nucleic Acids Res. 2017 Jan 4;45(D1):D896-D901
pubmed: 27899670
J Biol Inorg Chem. 2010 Mar;15(3):441-58
pubmed: 20035360
Nat Genet. 2006 Aug;38(8):904-9
pubmed: 16862161
Scand J Work Environ Health. 1983 Aug;9(4):327-31
pubmed: 6635611
Environ Res. 2016 May;147:356-64
pubmed: 26945432
J Lipid Res. 2006 Jan;47(1):59-66
pubmed: 16264198
Biochem Pharmacol. 1972 Oct 15;21(20):2767-71
pubmed: 4647082
Epidemiology. 2013 May;24(3):421-9
pubmed: 23514838
Environ Health Perspect. 2010 Jun;118(6):776-82
pubmed: 20053595
Am J Epidemiol. 2003 Feb 15;157(4):303-14
pubmed: 12578801
Am Indian Alsk Native Ment Health Res. 2000;9(3):20-37
pubmed: 11279560
Am J Hum Genet. 1998 May;62(5):1198-211
pubmed: 9545414
Environ Res. 2007 May;104(1):85-95
pubmed: 16996054
Front Genet. 2018 Oct 12;9:466
pubmed: 30369944
Am J Hum Genet. 2000 Mar;66(3):1076-94
pubmed: 10712219
Environ Health Perspect. 2014 Apr;122(4):363-70
pubmed: 24531129
Int J Environ Res Public Health. 2016 Mar 15;13(3):
pubmed: 26999173
Toxicol Lett. 2011 Nov 30;207(2):104-11
pubmed: 21911041
BMJ. 2018 Aug 29;362:k3310
pubmed: 30158148
Environ Res. 2015 Jan;136:227-33
pubmed: 25460641
Environ Res. 2007 Jan;103(1):30-7
pubmed: 16843453
Medicine (Baltimore). 2016 Mar;95(10):e2932
pubmed: 26962791
Toxicol Appl Pharmacol. 1984 Jul;74(3):299-307
pubmed: 6740679
Environ Health Perspect. 2018 Feb 21;126(2):027010
pubmed: 29467105
Toxicology. 1986 Sep;40(3):267-77
pubmed: 3750327
Environ Pollut. 2019 Dec;255(Pt 2):113329
pubmed: 31600704
Am J Epidemiol. 1990 Dec;132(6):1141-55
pubmed: 2260546
Food Chem Toxicol. 2017 Feb;100:239-246
pubmed: 28012896
Hum Mol Genet. 2015 Aug 15;24(16):4739-45
pubmed: 26025379
Environ Health Perspect. 2000 Aug;108(8):719-22
pubmed: 10964791
Int J Epidemiol. 2017 Dec 1;46(6):1903-1912
pubmed: 29025072
J Trace Elem Med Biol. 2005;19(1):13-7
pubmed: 16240666
Hum Mol Genet. 2016 Sep 15;25(18):4117-4126
pubmed: 27466201
Bioinformatics. 2010 Sep 1;26(17):2190-1
pubmed: 20616382
Nat Genet. 1995 Nov;11(3):241-7
pubmed: 7581446
ISRN Toxicol. 2013 Jan 27;2013:892364
pubmed: 23724302
J Biol Chem. 2014 Nov 7;289(45):30880-8
pubmed: 25281745
J Clin Endocrinol Metab. 2015 Feb;100(2):E345-9
pubmed: 25412415
Environ Health Perspect. 2020 Jun;128(6):67005
pubmed: 32484362
Toxicol Appl Pharmacol. 2011 Oct 1;256(1):1-7
pubmed: 21767559
Biometals. 2010 Oct;23(5):857-75
pubmed: 20204475
Environ Health Perspect. 2017 Jan;125(1):15-22
pubmed: 27352405
Environ Pollut. 2020 Sep;264:114627
pubmed: 32375089
Am J Hum Genet. 2002 Feb;70(2):496-508
pubmed: 11791215

Auteurs

Maria Grau-Perez (M)

Area of Cardiometabolic and Renal Risk, Institute for Biomedical Research Hospital Clinic of Valencia (INCLIVA), Valencia, Valencia, Spain; Department of Preventive Medicine and Public Health and Microbiology, Universidad Autonoma de Madrid, Madrid, Madrid, Spain; Department of Statistics and Operational Research, University of Valencia, Valencia, Spain. Electronic address: mgrau@incliva.es.

V Saroja Voruganti (VS)

Department of Nutrition and Nutrition Research Institute, Gillings School of Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Poojitha Balakrishnan (P)

School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.

Karin Haack (K)

Population Health Program, Texas Biomedical Research Institute, San Antonio, TX, USA.

Walter Goessler (W)

Institute of Chemistry - Analytical Chemistry, Karl-Franzens University of Graz, Graz, Austria.

Nora Franceschini (N)

Department of Epidemiology, Gillings School of Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Josep Redón (J)

Area of Cardiometabolic and Renal Risk, Institute for Biomedical Research Hospital Clinic of Valencia (INCLIVA), Valencia, Valencia, Spain; Department of Internal Medicine, Hospital Clinic of Valencia, University of Valencia, Valencia, Valencia, Spain.

Shelley A Cole (SA)

Population Health Program, Texas Biomedical Research Institute, San Antonio, TX, USA.

Ana Navas-Acien (A)

Department of Environmental Health Sciences, Columbia University, New York, NY, USA.

Maria Tellez-Plaza (M)

Area of Cardiometabolic and Renal Risk, Institute for Biomedical Research Hospital Clinic of Valencia (INCLIVA), Valencia, Valencia, Spain; Department of Preventive Medicine and Public Health and Microbiology, Universidad Autonoma de Madrid, Madrid, Madrid, Spain; Department of Chronic Diseases Epidemiology, National Center for Epidemiology, Instituto de Salud Carlos III, Madrid, Madrid, Spain; Department of Environmental Health and Engineering, Johns Hopkins University, Baltimore, MD, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH